228 related articles for article (PubMed ID: 28133873)
1. The future of immunotherapy for canine atopic dermatitis: a review.
DeBoer DJ
Vet Dermatol; 2017 Feb; 28(1):25-e6. PubMed ID: 28133873
[TBL] [Abstract][Full Text] [Related]
2. [Intralymphatic immunotherapy: An effective and safe alternative route for canine atopic dermatitis].
Fischer N; Rostaher A; Favrot C
Schweiz Arch Tierheilkd; 2016 Sep; 158(9):646-652. PubMed ID: 27655164
[TBL] [Abstract][Full Text] [Related]
3. The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy.
Griffin CE; Hillier A
Vet Immunol Immunopathol; 2001 Sep; 81(3-4):363-83. PubMed ID: 11553398
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases.
Fennis EEM; van Damme CMM; Schlotter YM; Sinke JD; Leistra MHG; Bartels RT; Broere F
Vet Dermatol; 2022 Aug; 33(4):321-e75. PubMed ID: 35635279
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of the effect of pullulan-conjugated Der f 2 allergen-specific immunotherapy on canine atopic dermatitis.
Kawano K; Mizuno T
Vet Dermatol; 2017 Dec; 28(6):583-e141. PubMed ID: 28776792
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of rush immunotherapy with alum-precipitated allergens in canine atopic dermatitis.
Hobi S; Mueller RS
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2014; 42(3):167-73. PubMed ID: 24920143
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of regionally-specific immunotherapy for the management of canine atopic dermatitis.
Plant JD; Neradilek MB
BMC Vet Res; 2017 Jan; 13(1):4. PubMed ID: 28056956
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy.
Keppel KE; Campbell KL; Zuckermann FA; Greeley EA; Schaeffer DJ; Husmann RJ
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):337-44. PubMed ID: 18423890
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of immunotherapy in dogs with atopic dermatitis using a mannan-Dermatophagoides farinae allergoid targeting dendritic cells.
González JL; Zalve V; Fernández-Caldas E; Cases B; Subiza JL; Casanovas M
Vet Dermatol; 2018 Oct; 29(5):449-e152. PubMed ID: 30183126
[TBL] [Abstract][Full Text] [Related]
10. Requirement for additional treatment for dogs with atopic dermatitis undergoing allergen-specific immunotherapy.
Colombo S; Hill PB; Shaw DJ; Thoday KL
Vet Rec; 2007 Jun; 160(25):861-4. PubMed ID: 17586789
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 10 and transforming growth factor-beta 1 plasma levels in atopic dogs before and during immunotherapy.
Martini F; Rostaher A; Favrot C; Fischer N
Vet Rec; 2022 Jun; 190(12):e1270. PubMed ID: 34939678
[TBL] [Abstract][Full Text] [Related]
12. Rush sublingual immunotherapy in canine atopic dermatitis: a prospective pilot study.
Fujimura M; Ishimaru H
Pol J Vet Sci; 2016; 19(1):3-6. PubMed ID: 27096781
[TBL] [Abstract][Full Text] [Related]
13. Effect of Allergen-Specific Immunotherapy on Transcriptomic Changes in Canine Atopic Dermatitis.
Majewska A; Gajewska M; Dembele K
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511372
[TBL] [Abstract][Full Text] [Related]
14. Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study.
Mueller RS; Veir J; Fieseler KV; Dow SW
Vet Dermatol; 2005 Feb; 16(1):61-8. PubMed ID: 15725107
[TBL] [Abstract][Full Text] [Related]
15. Immunoproteomic characterization of Ambrosia artemisiifolia pollen allergens in canine atopic dermatitis.
Ognjenovic J; Milcic-Matic N; Smiljanic K; Vuckovic O; Burazer L; Popovic N; Stanic-Vucinic D; Velickovic TC
Vet Immunol Immunopathol; 2013 Sep; 155(1-2):38-47. PubMed ID: 23830203
[TBL] [Abstract][Full Text] [Related]
16. Immunoproteomic characterization of a Dermatophagoides farinae extract used in the treatment of canine atopic dermatitis.
Moya R; Carnés J; Sinovas N; Ramió L; Brazis P; Puigdemont A
Vet Immunol Immunopathol; 2016 Nov; 180():1-8. PubMed ID: 27692089
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of subcutaneous, intralymphatic and sublingual immunotherapy for the long-term control of dogs with nonseasonal atopic dermatitis.
Fischer NM; Rostaher A; Favrot C
Vet Dermatol; 2020 Oct; 31(5):365-e96. PubMed ID: 32537789
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of intralymphatic immunotherapy (ILIT) on canine atopic dermatitis.
Timm K; Mueller RS; Nett-Mettler CS
Vet Dermatol; 2018 Apr; 29(2):123-e49. PubMed ID: 29327474
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the safety of an abbreviated course of injections of allergen extracts (rush immunotherapy) for the treatment of dogs with atopic dermatitis.
Mueller RS; Bettenay SV
Am J Vet Res; 2001 Mar; 62(3):307-10. PubMed ID: 11277192
[TBL] [Abstract][Full Text] [Related]
20. A survey of primary care practitioners' referral habits and recommendations of allergen-specific immunotherapy for canine and feline patients with atopic dermatitis.
Flanagan S; Schick A; Lewis TP; Chu Tater K; Rishniw M
Vet Dermatol; 2021 Apr; 32(2):106-e21. PubMed ID: 33275300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
